Email this article 
Treatment of vulvovaginites caused by opportunistic microorganisms. Current concepts and efficacyassessment
- Authors: Shatalova AY.1, Shatalova AY.1
-
Affiliations:
- Issue: Vol 87, No 4 (2011)
- Pages: 46-52
- Section: Articles
- Submitted: 11.03.2020
- Published: 15.08.2011
- URL: https://vestnikdv.ru/jour/article/view/1037
- DOI: https://doi.org/10.25208/vdv1037
- ID: 1037
Cite item
Full Text
Abstract
The author describes current approaches to treatment of vulvovaginites caused by opportunistic microorganisms.
The author assessed clinical and microbiological efficacy of different methods of treatment used for this pathology.
The author assessed clinical and microbiological efficacy of different methods of treatment used for this pathology.
References
- Воропаева С.Д. Микрофлора женских половых путей и ее чувствительность к антибактериальным препаратам. Антибиотики и химиотерапия 1999; 3: 42-45.
- Герасимова Н.М. Особенности диагностики аэробного вагинита. Сибир. журн. дерматол. и венерол. 2004; 5: 74-78.
- Коршунов В.М., Володин Н.Н., Ефимов Б.А. и др. Микроэкология влагалища. Коррекция микрофлоры при вагинальных дисбактериозах. Учебное пособие. М.: ВУНМУ МЗ РФ, 1999. 80 с.
- Johnson L., Sabel A., Burman W.J. et al. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Am J Med 2008; 121: 10: 876-884.
- Reid G., Bruce A.W. Urogenital infections in women - Can probiotics help? Postgraduate Med J 2003; 79: 429-432.
- Tariq N., Jaffery T., Ayub R. et al. Frequency and antimicrobial susceptibility of aerobic vaginal isolates. J Coll Physicians Surg Pak 2006; 16: 3: 196-199.
- Beerepoot M.A., Stobberingh E.E., Geerlings S.E. A study of non-antibiotic versus antibiotic prophylaxis for recurrent urinary-tract infections in women (the NAPRUTI study). Ned Tijdschr Geneeskd 2006; 150: 10: 541-544.
- Falagas M.E., Betsi G.I., Tokas T. et al. Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies. Drugs 2006; 66: 9: 1253-1261.
- Gardiner G., Heinemann-Gijzen C., Madrenas J. et al. Oral administration of the probiotic combination Lactobacillus GR-1 and L.reuteri RC-14 for human instinal applications. Int Dairy J 2002.
- Reid G., Charbonneau D., Erb J. et al. Oral use of Lactobacillus rhamnosus GR-1 and Reuteri RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in healthy women. Immunol Med Microbiol 2003; 35: 131-134.
- Robert B.D., Tassone D.P. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: A review. Clin Therap 2008; 30: 453-468.
- Яфаев Р.Х., Зуева Л.П., Любимов А.В. Перспективы использования бактериофагов с лечебной и профилактической целью. Инфекционный контроль в ЛПУ. СПб., 1998. С. 55-58.
Supplementary files
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).